SCHEMBL2659448

SCHEMBL2659448

CCC(=O)c1ccc(NC(=O)CSC2C(c3ccccc3)=C(c3ccccc3)C(=O)N2Cc2ccc(OC)cc2)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ERCC5 P28715 1/20 0.38
FEN1 P39748 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
CDK5 Q00535 1/20 0.38
CDK5R1 Q15078 1/20 0.38
HDAC1 Q13547 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
VNN1 O95497 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2643159 0.92 MEN1 (0.40) MEN1KMT2AERCC5FEN1NPC1
SCHEMBL2644853 0.79 NR1H2 (0.43) MEN1KMT2AERCC5FEN1NPC1
SCHEMBL2644216 0.79 TSHR (0.41) MEN1KMT2ACDK5CDK5R1VNN1
SCHEMBL1618842 0.79 ALDH1A1 (0.42) MEN1KMT2ANPC1RAB9ACDK5
SCHEMBL2642709 0.77 MAPT (0.42) MEN1KMT2AVNN1TP53TSHR
SCHEMBL2643421 0.77 VNN1 (0.43) MEN1KMT2ANPC1RAB9AHDAC1
SCHEMBL2656449 0.76 TSHR (0.38) MEN1KMT2ANPC1RAB9ACDK5
SCHEMBL2643472 0.74 RAB9A (0.45) MEN1KMT2ANPC1RAB9ATP53
SCHEMBL2666710 0.74 MAPK1 (0.40) MEN1KMT2ANPC1RAB9ACDK5
SCHEMBL2643492 0.74 ALDH1A1 (0.53) MEN1KMT2ANPC1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680122-B2 Substituted pyrrolones as allosteric modulators of glucokinase JANSSEN PHARMACETICA N.V. (BE) 2014-03-25 US disclosed
US-8680122-B2 Substituted pyrrolones as allosteric modulators of glucokinase JANSSEN PHARMACETICA N.V. (BE) 2014-03-25 US disclosed
US-20070099937-A1 Substituted Pyrrolones As Allosteric Modulators of Glucokinase JANSSEN PHARMACEUTICA N.V. (BE) 2007-05-03 US disclosed
US-20070099937-A1 Substituted Pyrrolones As Allosteric Modulators of Glucokinase JANSSEN PHARMACEUTICA N.V. (BE) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099937-A1 Substituted Pyrrolones As Allosteric Modulators of Glucokinase GCK, GCKR, PDXK MEN1 4513/4885KMT2A 3063/4885ERCC5 4671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.